Blood Clot News and Research

RSS

A Blood Clot is a mass of blood that forms when blood platelets, proteins, and cells stick together. When a blood clot is attached to the wall of a blood vessel, it is called a thrombus. When it moves through the bloodstream and blocks the flow of blood in another part of the body, it is called an embolus.

Researchers create roadmap to integrin activation

Calling it an important technical advance in the study of the complex receptors and pathways of the body's cellular system, researchers at the University of California, San Diego (UCSD) School of Medicine have reconstructed the signaling pathways that impact activation of a receptor that is critical to the control of bleeding and to the thrombosis that occurs in heart attacks and strokes.

18 Sep 2006

Elective Caesarean births put babies at three times the risk of dying

Researchers in the U.S. say that babies born by Caesarean section rather than normal birth, are three times more likely to die.

7 Sep 2006

UIC receives $20 million NCI grant to research blood disorders

A $19.6 million National Cancer Institute grant has been awarded to the University of Illinois at Chicago College of Medicine to advance basic and clinical research for incurable blood disorders.

6 Sep 2006

Tenecteplase study halted

World Congress of Cardiology 2006 - Thrombolytic Therapy, given during cardiopulmonary resuscitation (CPR) in out-ofhospital cardiac arrests, may be no better than placebo.

6 Sep 2006

Ultrasound targets angioplasty

World Congress of Cardiology 2006 - A simple technique - combining cardiac ultrasound with a heart muscle-stimulating drug - can identify the MI patients who would benefit most from angioplasty after thrombolysis, reports a study in Hot Line session II.

6 Sep 2006

Test on viability of heart muscle identifies patients who will benefit from angioplasty after clot-lysing therapy for an acute heart attack

Emergency angioplasty (balloondilation of the coronary vessel) is the preferred treatment for patients with an acute heart attack. Because of its limited availability worldwide, the majority of patients who are admitted to the hospital with a heart-attack are treated with clot-lysing drugs (thrombolysis).

5 Sep 2006

Aspirin resistance: Fact or fable?

Coronary heart disease is the single leading cause of death in the Western world. Aspirin is a fundamental part of the prevention and treatment of coronary heart disease and is used by millions of patients worldwide.

5 Sep 2006

Preventing bleeding is key to the treatment of acute coronary syndromes

On Monday, September 4 and Tuesday, September 5 at the World Congress of Cardiology, Dr. Christopher Granger presented data stressing the importance of prevention of bleeding as a key objective in treatment of acute coronary syndromes.

5 Sep 2006

Simple bedside test may identify heart attack risk

The reason behind why patients who are on aspirin still have heart attacks is an important topic in cardiovascular disease.

5 Sep 2006

How effective is continued Plavix therapy in patients undergoing a repeat stent procedure?

Clopidogrel (Plavix) is used worldwide in millions of patients after placement of coronary artery stents. Sales of the drug exceed 5 billion US dollars.

5 Sep 2006

New research could help women facing high risk of stillbirth

The risk of stillbirth is particularly high for women with Type 1 or Type 2 diabetes who suffer four times as many stillbirths as non-diabetic women.

5 Sep 2006

Venacavoscopy assisted inferior Vena cava thrombus resection for T3b/c renal cell carcinoma

Resection of intrahepatic and suprahepatic inferior vena cava (IVC) thrombi associated with renal cell carcinoma (RCC) can be surgically demanding procedures that can involve multidisciplinary surgical teams.

5 Sep 2006

Drug-coated stents increase the risk of blood clots

Heart experts attending the World Congress of Cardiology have expressed their concerns over the long-term safety record of drug-coated stents.

5 Sep 2006

Eastern Europe, Middle East has highest rates of cardiovascular disease deaths

Eastern European and Middle Eastern patients with diseased blood vessels have the highest rates of heart attacks and strokes, and the highest rates of death from those conditions, compared with similar patients in other regions of the world.

4 Sep 2006

A tissue marker of poor prognosis in clear cell renal cell carcinoma

The search for molecular markers that further advance our knowledge of the biology of renal cell carcinoma (RCC) and assist in evaluating the diagnosis and prognosis of patients remains the subject of intense investigation.

20 Aug 2006

Strokes more likely to occur early morning and early evening

Japanese scientists have found that strokes are most likely to occur during certain two-hour periods; one in the morning and the other in the evening.

20 Aug 2006

FDA approves Plavix for STEMI heart attacks

The Food and Drug Administration (FDA) today approved the use of Plavix (clopidogrel bisulfate) for patients who have had a type of heart attack called acute ST-segment elevation myocardial infarction (STEMI), who are not going to have coronary artery repair (angioplasty).

17 Aug 2006